<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>
Creso Pharma Ltd (ASX:CPH, OTCQB:COPHF) subsidiary Halucenex Life Sciences Inc has been invited by Health Canada to become a potential supplier of psychedelics like psilocybin under the new Special Access Program (SAP) in Canada, unlocking potential revenue-generating opportunities. The SAP announced on January 5, 2022, creates a framework of regulatory changes that allow medical professionals to request access to previously restricted drugs such as psilocybin for emergency treatment purposes.
...read full article on Proactive Investors
